28 01/03/2023 29/02/2024 2024-02-29 false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2023-03-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 07148874 2023-03-01 2024-02-29 07148874 2024-02-29 07148874 2023-02-28 07148874 2022-03-01 2023-02-28 07148874 2023-02-28 07148874 2022-02-28 07148874 core:NetGoodwill 2023-03-01 2024-02-29 07148874 core:PlantMachinery 2023-03-01 2024-02-29 07148874 core:FurnitureFittingsToolsEquipment 2023-03-01 2024-02-29 07148874 bus:RegisteredOffice 2023-03-01 2024-02-29 07148874 bus:LeadAgentIfApplicable 2023-03-01 2024-02-29 07148874 bus:Director1 2023-03-01 2024-02-29 07148874 bus:Director2 2023-03-01 2024-02-29 07148874 bus:Director3 2023-03-01 2024-02-29 07148874 bus:Director4 2023-03-01 2024-02-29 07148874 bus:Director5 2023-03-01 2024-02-29 07148874 bus:Director6 2023-03-01 2024-02-29 07148874 bus:CompanySecretary1 2023-03-01 2024-02-29 07148874 core:NetGoodwill 2023-02-28 07148874 core:NetGoodwill 2024-02-29 07148874 core:PlantMachinery 2023-02-28 07148874 core:FurnitureFittingsToolsEquipment 2023-02-28 07148874 core:PlantMachinery 2024-02-29 07148874 core:FurnitureFittingsToolsEquipment 2024-02-29 07148874 core:AfterOneYear 2024-02-29 07148874 core:AfterOneYear 2023-02-28 07148874 core:RetainedEarningsAccumulatedLosses 2022-03-01 2023-02-28 07148874 core:RetainedEarningsAccumulatedLosses 2023-03-01 2024-02-29 07148874 core:WithinOneYear 2024-02-29 07148874 core:WithinOneYear 2023-02-28 07148874 core:ShareCapital 2024-02-29 07148874 core:ShareCapital 2023-02-28 07148874 core:RetainedEarningsAccumulatedLosses 2024-02-29 07148874 core:RetainedEarningsAccumulatedLosses 2023-02-28 07148874 core:PreviouslyStatedAmount core:ShareCapital 2022-02-28 07148874 core:PreviouslyStatedAmount core:RetainedEarningsAccumulatedLosses 2022-02-28 07148874 core:PreviouslyStatedAmount 2022-02-28 07148874 core:ShareCapital 2022-02-28 07148874 core:RetainedEarningsAccumulatedLosses 2022-02-28 07148874 core:PreviouslyStatedAmount core:ShareCapital 2024-02-29 07148874 core:NetGoodwill 2023-02-28 07148874 core:PlantMachinery 2023-02-28 07148874 core:FurnitureFittingsToolsEquipment 2023-02-28 07148874 bus:SmallEntities 2023-03-01 2024-02-29 07148874 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 07148874 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 07148874 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 07148874 bus:FullAccounts 2023-03-01 2024-02-29
Company registration number: 07148874
All Health Matters Limited
Trading as All Health Matters
Unaudited filleted financial statements
29 February 2024
All Health Matters Limited
Contents
Directors and other information
Accountants report
Statement of financial position
Statement of changes in equity
Notes to the financial statements
All Health Matters Limited
Directors and other information
Directors Mrs Gillian Monk
Mr David Drury Monk
Dr Frixos Kopsacheilis
Mrs Rachel Helen Day
Mr Andrew J Llewellyn-Davis
Miss Alice Gillian Monk
Secretary Mrs Gillian Monk
Company number 07148874
Registered office Bank Chambers
Canterbury Road
Lyminge
Nr Folkestone
CT18 8HU
Business address Castle House
Orchard Close Mews
Canterbury
Kent
CT2 8AP
Accountants Norman Brisk & Company Limited
Bank Chambers
Canterbury Road
Lyminge Nr Folkestone
Kent
CT18 8HU
All Health Matters Limited
Report to the board of directors on the preparation of the
unaudited statutory financial statements of All Health Matters Limited
Year ended 29 February 2024
As described on the Statement of financial position, the directors of the company are responsible for the preparation of the financial statements for the year ended 29 February 2024, as set out on pages 5 to 12.
You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.
Norman Brisk & Company Limited
Business Advisers and Taxation Consultants
Bank Chambers
Canterbury Road
Lyminge Nr Folkestone
Kent
CT18 8HU
2 September 2024
All Health Matters Limited
Statement of financial position
29 February 2024
2024 2023
Note £ £ £ £
Fixed assets
Intangible assets 5 10,000 20,000
Tangible assets 6 84,916 70,294
_______ _______
94,916 90,294
Current assets
Debtors 7 300,552 211,073
Cash at bank and in hand 118,999 182,075
_______ _______
419,551 393,148
Creditors: amounts falling due
within one year 8 ( 219,632) ( 208,744)
_______ _______
Net current assets 199,919 184,404
_______ _______
Total assets less current liabilities 294,835 274,698
Creditors: amounts falling due
after more than one year 9 ( 26,849) ( 32,180)
_______ _______
Net assets 267,986 242,518
_______ _______
Capital and reserves
Called up share capital 100 100
Profit and loss account 267,886 242,418
_______ _______
Shareholders funds 267,986 242,518
_______ _______
For the year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 02 September 2024 , and are signed on behalf of the board by:
Mrs Gillian Monk
Director
All Health Matters Limited
Statement of changes in equity
Year ended 29 February 2024
Called up share capital Profit and loss account Total
£ £ £
At 1 March 2022 (as previously reported) 100 300,244 300,344
Prior period adjustments (-) (4,900) (4,900)
_______ _______ _______
At 1 March 2022 (restated) 100 295,344 295,444
Profit for the year 117,074 117,074
_______ _______ _______
Total comprehensive income for the year - 117,074 117,074
Equity settled share-based payments ( 170,000) ( 170,000)
_______ _______ _______
Total investments by and distributions to owners - ( 170,000) ( 170,000)
_______ _______ _______
At 28 February 2023 and 1 March 2023 100 242,418 242,518
Profit for the year 192,968 192,968
_______ _______ _______
Total comprehensive income for the year - 192,968 192,968
Equity settled share-based payments ( 167,500) ( 167,500)
_______ _______ _______
At 29 February 2024 100 267,886 267,986
_______ _______ _______
All Health Matters Limited
Notes to the financial statements
Year ended 29 February 2024
1. General information
The company is a private company limited by shares, registered in England. The address of the registered office is Bank Chambers, Canterbury Road, Lyminge, Nr Folkestone, CT18 8HU.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Goodwill
Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Goodwill - 33.33 % straight line
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant and machinery - 10 % reducing balance
Fittings fixtures and equipment - 10 % reducing balance
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 28 (2023: 25 ).
5. Intangible assets
Goodwill Total
£ £
Cost
At 1 March 2023 and 29 February 2024 30,000 30,000
_______ _______
Amortisation
At 1 March 2023 10,000 10,000
Charge for the year 10,000 10,000
_______ _______
At 29 February 2024 20,000 20,000
_______ _______
Carrying amount
At 29 February 2024 10,000 10,000
_______ _______
At 28 February 2023 20,000 20,000
_______ _______
6. Tangible assets
Plant and machinery Fixtures, fittings and equipment Total
£ £ £
Cost
At 1 March 2023 133,755 70,820 204,575
Additions 18,496 5,561 24,057
_______ _______ _______
At 29 February 2024 152,251 76,381 228,632
_______ _______ _______
Depreciation
At 1 March 2023 80,562 53,719 134,281
Charge for the year 6,452 2,983 9,435
_______ _______ _______
At 29 February 2024 87,014 56,702 143,716
_______ _______ _______
Carrying amount
At 29 February 2024 65,237 19,679 84,916
_______ _______ _______
At 28 February 2023 53,193 17,101 70,294
_______ _______ _______
7. Debtors
2024 2023
£ £
Trade debtors 267,076 184,101
Other debtors 33,476 26,972
_______ _______
300,552 211,073
_______ _______
8. Creditors: amounts falling due within one year
2024 2023
£ £
Trade creditors 254 42,416
Corporation tax 57,442 28,092
Social security and other taxes 137,373 126,290
Other creditors 24,563 11,946
_______ _______
219,632 208,744
_______ _______
9. Creditors: amounts falling due after more than one year
2024 2023
£ £
Bank loans and overdrafts 26,849 32,180
_______ _______
10. Controlling party
On 25th March 2021, the controlling party became All Health Matters Trustee Limited. The Trust holds the issued and fully paid up share capital of the company.